Edited by:
Sabina Ševčíková, PhD, Masaryk University, Czechia
Submission Status: Open | Submission Deadline: 8 December 2025
New Biomarkers of Solid and Hematological Malignancies
About the Collection
Cancer remains the second leading cause of mortality globally, responsible for approximately 10 million deaths every year. Over the past decade, advancements in therapeutic strategies have significantly enhanced patient survival rates. Novel diagnostic and prognostic biomarkers have been identified, facilitating more personalized treatment approaches.
This Collection focuses on the latest discoveries of biomarkers in both solid and hematological malignancies, aiming to highlight their potential in improving cancer diagnosis, prognosis, and personalized therapy.
There are currently no articles in this collection.
Submission Guidelines
Back to topThis Collection welcomes submissions of original research and review articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “New Biomarkers of Solid and Hematological Malignancies" under the “Details” tab during the submission stage.
Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.